Sg Americas Securities, LLC Intellia Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 24,144 shares of NTLA stock, worth $353,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,144
Previous 6,197 289.61%
Holding current value
$353,709
Previous $139,000 256.83%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$19.72 - $27.36 $353,914 - $491,029
17,947 Added 289.61%
24,144 $496,000
Q2 2024

Jul 12, 2024
BUY
$20.02 - $27.22 $7,327 - $9,962
366 Added 6.28%
6,197 $139,000
Q1 2024

May 06, 2024
BUY
$23.82 - $32.8 $138,894 - $191,256
5,831 New
5,831 $160,000
Q2 2023

Jul 10, 2023
SELL
$34.58 - $46.03 $367,481 - $489,160
-10,627 Reduced 52.66%
9,552 $390,000
Q1 2023

Apr 28, 2023
BUY
$33.3 - $44.82 $7,292 - $9,815
219 Added 1.1%
20,179 $752,000
Q4 2022

Feb 02, 2023
BUY
$33.21 - $62.69 $301,480 - $569,099
9,078 Added 83.42%
19,960 $696,000
Q3 2022

Oct 31, 2022
BUY
$53.92 - $71.7 $208,292 - $276,977
3,863 Added 55.04%
10,882 $609,000
Q2 2022

Jul 29, 2022
SELL
$38.49 - $76.21 $570,190 - $1.13 Million
-14,814 Reduced 67.85%
7,019 $363,000
Q1 2022

Apr 29, 2022
SELL
$58.27 - $118.99 $583,690 - $1.19 Million
-10,017 Reduced 31.45%
21,833 $1.59 Million
Q4 2021

Feb 07, 2022
BUY
$100.76 - $138.36 $1.75 Million - $2.4 Million
17,323 Added 119.25%
31,850 $3.77 Million
Q3 2021

Nov 01, 2021
BUY
$132.37 - $176.78 $587,722 - $784,903
4,440 Added 44.02%
14,527 $1.95 Million
Q2 2021

Aug 12, 2021
SELL
$60.88 - $161.91 $72,995 - $194,130
-1,199 Reduced 10.62%
10,087 $1.63 Million
Q1 2021

May 13, 2021
BUY
$46.59 - $83.68 $239,891 - $430,868
5,149 Added 83.9%
11,286 $906,000
Q4 2020

Feb 04, 2021
SELL
$18.83 - $63.53 $630,051 - $2.13 Million
-33,460 Reduced 84.5%
6,137 $334,000
Q3 2020

Nov 09, 2020
BUY
$17.47 - $24.93 $90,319 - $128,888
5,170 Added 15.02%
39,597 $787,000
Q2 2020

Jul 20, 2020
BUY
$11.14 - $22.87 $383,516 - $787,345
34,427 New
34,427 $724,000
Q1 2019

Apr 29, 2019
SELL
$12.79 - $17.62 $105,376 - $145,171
-8,239 Closed
0 $0
Q4 2018

Feb 01, 2019
BUY
$11.39 - $27.13 $93,842 - $223,524
8,239 New
8,239 $112,000
Q2 2018

Aug 07, 2018
SELL
$20.02 - $30.79 $860,059 - $1.32 Million
-42,960 Closed
0 $0
Q1 2018

May 03, 2018
BUY
$19.43 - $34.95 $834,712 - $1.5 Million
42,960 New
42,960 $906,000
Q4 2017

Jan 24, 2018
SELL
$17.39 - $31.12 $176,838 - $316,459
-10,169 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$15.16 - $25.75 $154,162 - $261,851
10,169
10,169 $253,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.11B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email